Inventor · disambiguated record
Asrar Malik
Also filed as: MALIK ASRAR · MALIK ASRAR B · MALIK ASRAR BARI
13 granted patents·9 pending applications·68 citations·filing 1996–2022
89Inventor score
Top patents by PatentIndex Score
22 records- 0186US9561192B2Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory diseaseUNIV ILLINOIS·Filed 2014·Granted Feb 7, 2017·4 cites·27 claims
- 0284US9872839B2Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory diseaseUNIV ILLINOIS·Filed 2017·Granted Jan 23, 2018·2 cites·13 claims
- 0379US8067389B2Silencing of TGFβ type II receptor expression by siRNAKUMAR NALIN M·Filed 2009·Granted Nov 29, 2011·12 cites·13 claims
- 0476US7429563B2Peptide carrier for drug deliveryUNIV ILLINOIS·Filed 2006·Granted Sep 30, 2008·1 cites·14 claims
- 0575US2023048872A1Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory diseaseUNIV ILLINOIS·Filed 2022·Application pending·0 cites
- 0673US6204054B1Transcytosis vehicles and enchancers for drug deliveryANDARIS LTD·Filed 1996·Granted Mar 20, 2001·43 cites·15 claims
- 0772US7825101B2Modulation of MLCK-L expression and uses thereofUNIV ILLINOIS·Filed 2007·Granted Nov 2, 2010·3 cites·4 claims
- 0870US8912139B2Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestionUNIV ILLINOIS·Filed 2014·Granted Dec 16, 2014·2 cites·13 claims
- 0967US2021008003A1Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory diseaseUNIV ILLINOIS·Filed 2020·Application pending·0 cites
- 1064US2019224139A1Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory diseaseUNIV ILLINOIS·Filed 2018·Application pending·0 cites
- 1163US8168176B2CBLB for treating endotoxin-mediated disordersBACHMAIER KURT·Filed 2007·Granted May 1, 2012·1 cites·8 claims
- 1252US11299524B2KIF13B-derived peptide and method of inhibiting angiogenesisUNIV ILLINOIS·Filed 2017·Granted Apr 12, 2022·0 cites·13 claims
- 1350US10064911B2Peptides for treating cancerUNIV ILLINOIS·Filed 2017·Granted Sep 4, 2018·0 cites·18 claims
- 1445US9675660B2Peptides for inhibiting angiogenesisUNIV ILLINOIS·Filed 2016·Granted Jun 13, 2017·0 cites·18 claims
- 1543US2006229266A1Silencing of tgf-beta receptor type II expression by sirnaKUMAR NALIN M·Filed 2004·Application pending·0 cites
- 1643US2023193235A1Modified angiotensin-converting enzyme 2 (ace2) and use thereofUNIV ILLINOIS·Filed 2021·Application pending·0 cites
- 1742US9248198B2Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestionKOMAROVA YULIA A·Filed 2012·Granted Feb 2, 2016·0 cites·6 claims
- 1842US2011171193A1Compositions and methods for treating pulmonary hypertensionUNIV ILLINOIS·Filed 2009·Application pending·0 cites
- 1937US2008160552A1Methods and Compounds for Treating InflammationMEHTA DOLLY·Filed 2007·Application pending·0 cites
- 2037US2011092568A1Modulation of mlck-l expression and uses thereofUNIV ILLINOIS·Filed 2010·Application pending·0 cites
- 2136US8137968B2Selected endothelial progenitor cells and methods for useWARY KISHORE K·Filed 2008·Granted Mar 20, 2012·0 cites·2 claims
- 2231US2016168538A1Flk1+ and VE-Cadherin+ Endothelial Cells Derived from iPS or ES Cells, and Methods of Preparing and Using the SameUNIV ILLINOIS·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →